1008: ADHD Across the Lifespan: Biologic Components and Contemporary Issues of Clinical Management
Speaker: Philip Shaw, MD, PhD Earl Stadtman Investigator, Section on Neurobehavioral Clinical Research, Social and Behavioral Research Branch, National Human Genome Research Institute, and Adjunct Faculty, National Institute of Mental Health (NIMH)
Disclosures: Discussion of off-label uses will take place during this presentation. The speaker and the activity planners have no conflicts of interest to disclose.
Session Length: 105 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
1. Appreciate that ADHD can be a challenge not just for children but also for adults.
2. Recognize that there are subtle changes in the brain and its development which are associated with ADHD
3. Discuss genes which confer a slight increase in the risk for ADHD
4. Demonstrate that neither neuroimaging nor genetic testing islet useful in the clinical management of ADHD.
Continuing Nursing Education
1.75 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.
The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Saturday, June 22, 2013 9:45am11:15am
APNA 11th Annual Clinical Psychopharmacology Institute
Release Date: August 5, 2013
The contact hours for this session expire: December 1, 2016